Excretion accelerator for accumulative chlorine compound
View Patent ↗An agent for promoting excretion of an accumulative chlorine compound comprising a pharmaceutically acceptable anion exchange resin, which is a novel agent that is for promoting the excretion of an accumulative chlorine compound and is capable of efficiently excreting residual chlorinated compounds including dioxins as typical examples.
1. The method for promoting excretion of an accumulated dioxin in a human patient in need thereof, said method consisting essentially of administering colestimide as the sole active ingredient to the human patient in need thereof.
2. The method for promoting excretion of an accumulated dioxin in a human patient in need thereof, said method comprising administering colestimide as the sole active ingredient to the human patient in need thereof, wherein the colestimide is excreted with the accumulated dioxin.
3. The method for promoting excretion of an accumulative dioxin in a human patient in need thereof, said method comprising administering colestimide as the sole active ingredient to the human patient in need thereof, wherein the colestimide absorbs the accumulated dioxin, and the colestimide is excreted with the accumulated dioxin.
4. The method for promoting excretion of an accumulative in a human patient in need thereof, said method comprising administering colestimide as the sole active ingredient to the human patient in need thereof, wherein the colestimide is excreted with the accumulated dioxin.
5. A method for absorbing an accumulated dioxin in a human patient in need thereof, said method consisting essentially of administering colestimide as an active ingredient to the human patient in need thereof, wherein the colestimide absorbs the accumulated dioxin.
6. The method according to any one of claims 1 - 5 , wherein the human patient is on with yusho or toxicosis caused by a dioxin.
7. The method according to any one of claims 1 - 5 , wherein the human patient is on with yusho.
8. The method according to any one of claims 1 - 5 , wherein the human patient is one with toxicosis caused by a dioxin.
9. The method according to any one of claims 1 - 5 , wherein the dioxin has a chemical structure as represented by the following formula (I) or (II):
wherein 1 to 8 chlorine atoms are substituted at any of positions 1 to 4 and 6 to 9.
10. The method according to claim 9 , wherein the dioxin has a chemical structure as represented by the formula (I) or (II) wherein chlorine atoms are substituted at positions 2, 3, 7, and 8.
11. The method according to claim 10 , wherein the dioxin has a chemical structure as represented by the formula (I) wherein chlorine atoms are substituted at positions 2, 3, 7, and 8.
12. The method according to claim 10 , wherein the dioxin has a chemical structure as represented by the formula (II) wherein chlorine atoms are substituted at positions 2, 3, 7, and 8.
13. The method according to any of claims 1 - 5 , wherein the dioxin is tetrachlorodibenzodioxin.